Skip to main content
# Title Department Research Year
61 Design-of-experiment approach to quantify the effect of nano-sized silica on tableting properties of microcrystalline cellulose to facilitate direct compression tableting of binary blend containing a low-dose drug Department of Industrial Pharmacy 2022
62 Development and validation of a novel evaporation setup-assisted TLC method with fluorescence detection for determination of flibanserin in pharmaceutical and biological samples Department of Pharmaceutical Analytical Chemistry 2022
63 Diverse Glycosides from Gardenia latifolia with Antiviral Activity and Chemosystematic Significance Department of Pharmacognosy 2022
64 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Department of Pharmaceutics 2022
65 Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity Department of Pharmaceutical Organic Chemistry 2022
66 Design, synthesis, crystal structures and biological evaluation of some 1, 3-thiazolidin-4-ones as dual CDK2/EGFR potent inhibitors with potential apoptotic antiproliferative effects 2022
67 Selective Cytotoxic Constituents from Gardenia latifolia and Their In Silico Topoisomerase IIα Inhibition Department of Pharmacognosy 2022
68 Design and optimization of PEGylated silver nanoparticles for efficient delivery of Doxorubicin to cancer cells Department of Industrial Pharmacy 2022
69 Emphasis on the incorporation of Tropaeolin OO dye and silver nanoparticles for voltammetric estimation of flibanserin in bulk form, tablets and human plasma Department of Pharmaceutical Analytical Chemistry 2022
70 Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis Department of Pharmaceutical Organic Chemistry 2022